Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost Of Revenue | 10,323 | 3,335 | 896.00 | 1,171 | 1,170 |
| Gross Profit | -10,323 | -3,335 | -896.00 | -1,171 | -1,170 |
| Selling General And Administration | 988,613 | 679,553 | 370,679 | 422,794 | 388,803 |
| General And Administrative Expense | 988,613 | 679,553 | 370,679 | 422,794 | 388,803 |
| Research And Development | 186,724 | 137,468 | 126,882 | 185,764 | 138,056 |
| Other Operating Expenses | 9.6M | 4.9M | 342,025 | 670,067 | 1.8M |
| Operating Expense | 10.7M | 5.7M | 839,586 | 1.3M | 2.3M |
| Operating Income | -10.7M | -5.7M | -840,482 | -1.3M | -2.4M |
| EBIT | -10.7M | -5.7M | -840,482 | -1.3M | -2.4M |
| Interest Expense | -- | -- | -- | 0.00 | 0.00 |
| Interest Expense Non Operating | -- | -- | -- | 0.00 | 0.00 |
| Interest Income | 74,290 | 19,096 | 9,522 | 15,084 | 2,404 |
| Interest Income Non Operating | 74,290 | 19,096 | 9,522 | 15,084 | 2,404 |
| Net Interest Income | 74,290 | 19,096 | 9,522 | 15,084 | 2,404 |
| Other Income Expense | 41,973 | -42,466 | -2,166 | -23,117 | 3,233 |
| Special Income Charges | -- | -- | -- | 0.00 | 0.00 |
| Gain On Sale Of Security | 41,973 | -42,466 | -2,166 | -23,117 | 3,233 |
| Pretax Income | -10.6M | -5.7M | -833,126 | -1.3M | -2.3M |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -10.6M | -5.7M | -833,126 | -1.3M | -2.3M |
| Net Income From Continuing Operation Net Minority Interest | -10.6M | -5.7M | -833,126 | -1.3M | -2.3M |
| Net Income Including Noncontrolling Interests | -10.6M | -5.7M | -833,126 | -1.3M | -2.3M |
| Net Income Common Stockholders | -10.6M | -5.7M | -833,126 | -1.3M | -2.3M |
| Net Income | -10.6M | -5.7M | -833,126 | -1.3M | -2.3M |
| EBITDA | -10.7M | -5.7M | -839,586 | -1.3M | -2.3M |
| Normalized EBITDA | -10.8M | -5.7M | -837,420 | -1.3M | -2.4M |
| Reconciled Depreciation | 10,323 | 3,335 | 896.00 | 1,171 | 1,170 |
| Basic EPS | -0.14 | -0.11 | -0.02 | -- | -0.07 |
| Diluted EPS | -0.14 | -0.11 | -0.02 | -- | -0.07 |
| Basic Average Shares | 77.4M | 53.5M | 42.0M | -- | 35.6M |
| Diluted Average Shares | 77.4M | 53.5M | 42.0M | -- | 35.6M |
| Total Unusual Items | 41,973 | -42,466 | -2,166 | -23,117 | 3,233 |
| Total Unusual Items Excluding Goodwill | 41,973 | -42,466 | -2,166 | -23,117 | 3,233 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -10.7M | -5.7M | -830,960 | -1.3M | -2.3M |
| Diluted NI Availto Com Stockholders | -10.6M | -5.7M | -833,126 | -1.3M | -2.3M |
| Gain On Sale Of Ppe | -- | -- | -- | 0.00 | 0.00 |
| Insurance And Claims | 10,661 | 13,947 | 13,231 | 11,647 | 11,825 |
| Net Income Continuous Operations | -10.6M | -5.7M | -833,126 | -1.3M | -2.3M |
| Net Non Operating Interest Income Expense | 74,290 | 19,096 | 9,522 | 15,084 | 2,404 |
| Other Gand A | 152,850 | 143,770 | 110,003 | 92,962 | 99,793 |
| Reconciled Cost Of Revenue | 10,323 | 3,335 | 896.00 | 1,171 | 1,170 |
| Salaries And Wages | 825,102 | 521,836 | 247,445 | 318,185 | 277,185 |
| Total Expenses | 10.7M | 5.7M | 840,482 | 1.3M | 2.4M |
| Total Operating Income As Reported | -- | -- | -- | -- | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 20.5M | 9.9M | 1.2M | 2.0M | 1.5M |
| Cash Cash Equivalents And Short Term Investments | 20.5M | 9.9M | 1.2M | 2.0M | 1.5M |
| Cash Financial | -- | -- | -- | -- | -- |
| Accounts Receivable | 44,530 | 37,985 | 9,358 | 12,902 | 71,600 |
| Receivables | 44,530 | 37,985 | 9,358 | 12,902 | 71,600 |
| Prepaid Assets | 1.1M | 1.1M | 562,661 | 631,264 | 551,921 |
| Current Assets | 21.6M | 11.0M | 1.8M | 2.6M | 2.1M |
| Gross PPE | 1.3M | 1.3M | 1.2M | 1.2M | 1.2M |
| Accumulated Depreciation | -60,262 | -49,939 | -46,604 | -45,708 | -131,430 |
| Net PPE | 1.3M | 1.2M | 1.2M | 1.2M | 1.1M |
| Total Non Current Assets | 1.3M | 1.2M | 1.2M | 1.2M | 1.1M |
| Total Assets | 22.9M | 12.2M | 2.9M | 3.8M | 3.2M |
| Accounts Payable | -- | -- | -- | 245,151 | -- |
| Payables | -- | -- | -- | 435,420 | -- |
| Payables And Accrued Expenses | 3.2M | 2.7M | 292,149 | 435,420 | 927,108 |
| Other Current Liabilities | -- | -- | -- | -- | 9,800 |
| Current Liabilities | 3.2M | 2.7M | 292,149 | 435,420 | 936,908 |
| Total Non Current Liabilities Net Minority Interest | 386,652 | 376,031 | 393,234 | 390,642 | 363,675 |
| Total Liabilities Net Minority Interest | 3.6M | 3.1M | 685,383 | 826,062 | 1.3M |
| Common Stock | 65.7M | 45.9M | 38.1M | 38.1M | 36.5M |
| Capital Stock | 65.7M | 45.9M | 38.1M | 38.1M | 36.5M |
| Retained Earnings | -61.1M | -50.5M | -44.7M | -43.9M | -42.6M |
| Gains Losses Not Affecting Retained Earnings | 14.7M | 13.7M | 8.8M | 8.7M | 8.0M |
| Common Stock Equity | 19.3M | 9.1M | 2.3M | 3.0M | 1.9M |
| Stockholders Equity | 19.3M | 9.1M | 2.3M | 3.0M | 1.9M |
| Total Equity Gross Minority Interest | 19.3M | 9.1M | 2.3M | 3.0M | 1.9M |
| Total Capitalization | 19.3M | 9.1M | 2.3M | 3.0M | 1.9M |
| Net Tangible Assets | 19.3M | 9.1M | 2.3M | 3.0M | 1.9M |
| Tangible Book Value | 19.3M | 9.1M | 2.3M | 3.0M | 1.9M |
| Working Capital | 18.4M | 8.3M | 1.5M | 2.2M | 1.2M |
| Invested Capital | 19.3M | 9.1M | 2.3M | 3.0M | 1.9M |
| Share Issued | 90.0M | 67.5M | 42.0M | 42.0M | 38.2M |
| Ordinary Shares Number | 90.0M | 67.5M | 42.0M | 42.0M | 38.2M |
| Dueto Related Parties Current | -- | -- | -- | 190,269 | -- |
| Long Term Provisions | 386,652 | 376,031 | 393,234 | 390,642 | 363,675 |
| Machinery Furniture Equipment | 82,210 | 43,648 | 34,975 | 34,975 | 34,975 |
| Other Properties | -- | -- | -- | -- | 86,893 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -9.3M | -3.7M | -760,616 | -1.4M | -1.8M |
| Cash Flow From Continuing Operating Activities | -9.3M | -3.7M | -760,616 | -1.4M | -1.8M |
| Depreciation And Amortization | 10,323 | 3,335 | 896.00 | 1,171 | 1,170 |
| Depreciation Amortization Depletion | 10,323 | 3,335 | 896.00 | 1,171 | 1,170 |
| Stock Based Compensation | 694,636 | 308,584 | 140,146 | 201,756 | 68,610 |
| Change In Working Capital | 600,758 | 1.7M | -72,506 | -522,359 | 524,547 |
| Change In Receivables | -6,545 | -28,627 | 3,544 | 58,698 | -62,724 |
| Change In Payables And Accrued Expense | 589,864 | 2.3M | -144,653 | -501,714 | 697,705 |
| Other Non Cash Items | 2,928 | 2,888 | 2,940 | 2,905 | 2,813 |
| Capital Expenditure | -38,562 | -- | -- | -91,514 | -- |
| Purchase Of PPE | -38,562 | -- | -- | 0.00 | 0.00 |
| Net PPE Purchase And Sale | -38,562 | -- | -- | 0.00 | 0.00 |
| Investing Cash Flow | -38,562 | -- | -- | -91,514 | 0.00 |
| Cash Flow From Continuing Investing Activities | -38,562 | -- | -- | -91,514 | 0.00 |
| Repayment Of Debt | -- | -- | -- | 0.00 | 0.00 |
| Net Issuance Payments Of Debt | -- | -- | -- | 0.00 | 0.00 |
| Issuance Of Capital Stock | 21.2M | -- | -- | 2.3M | 3.1M |
| Net Common Stock Issuance | 21.2M | -- | -- | 2.3M | 3.1M |
| Financing Cash Flow | 20.0M | -- | -- | 2.0M | 2.9M |
| Cash Flow From Continuing Financing Activities | 20.0M | -- | -- | 2.0M | 2.9M |
| Changes In Cash | 10.6M | 8.7M | -760,616 | 457,287 | 1.1M |
| Beginning Cash Position | 9.9M | 1.2M | 2.0M | 1.5M | 381,909 |
| End Cash Position | 20.5M | 9.9M | 1.2M | 2.0M | 1.5M |
| Free Cash Flow | -9.4M | -3.8M | -760,616 | -1.5M | -1.8M |
| Income Tax Paid Supplemental Data | 0.00 | 0.00 | 0.00 | -- | 0.00 |
| Interest Paid Supplemental Data | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Reported | 0.00 | -- | -- | -91,514 | 0.00 |
| Change In Prepaid Assets | 17,439 | -506,919 | 68,603 | -79,343 | -110,434 |
| Common Stock Issuance | 21.2M | -- | -- | 2.3M | 3.1M |
| Depreciation | 10,323 | 3,335 | 896.00 | 1,171 | 1,170 |
| Gain Loss On Sale Of PPE | -- | -- | -- | 0.00 | 0.00 |
| Long Term Debt Payments | -- | -- | -- | 0.00 | 0.00 |
| Net Foreign Currency Exchange Gain Loss | -7,995 | -18,625 | 1,034 | 24,062 | -5,836 |
| Net Income From Continuing Operations | -10.6M | -5.7M | -833,126 | -1.3M | -2.3M |
| Net Long Term Debt Issuance | -- | -- | -- | 0.00 | 0.00 |
| Net Other Financing Charges | -1.4M | -- | -- | -302,134 | -- |
| Operating Gains Losses | -7,995 | -18,625 | 1,034 | 24,062 | -5,836 |
| Proceeds From Stock Option Exercised | -- | -- | -- | 0.00 | 0.00 |
| Sale Of PPE | -- | -- | -- | 0.00 | 0.00 |